# A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.

> **NCT06487455** · PHASE1 · RECRUITING · sponsor: **Shanghai Pharmaceuticals Holding Co., Ltd** · enrollment: 170 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** SPH7485

## Key facts

- **NCT ID:** NCT06487455
- **Lead sponsor:** Shanghai Pharmaceuticals Holding Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-06
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06487455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06487455, "A Clinical Study of SPH7485 Tablets in the Treatment of Advanced Solid Tumors.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06487455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*